A phase II study of eribulin mesylate (E7389) in patients with advanced, previously treated non-small-cell lung cancer.
暂无分享，去创建一个
A. Das | N. Iannotti | N. Gabrail | A. Spira | M. Savin | M. Neubauer | D. Shuster | E. Zang | Patricia E. Cole | R. Yanagihara | Asha Das | Ronald Yanagihara | Michael A Savin | Marcus A. Neubauer | Edith A Zang | Patricia E Cole